Angiogenesis Inhibitors: all 4,430 studies that test it
Page 40 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)CompletedNCT00504400Phase 2
- A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)CompletedNCT00502112Phase 1
- CAPTAIN:Choroidal Neovascularization Assessment by Pattern ElectroretinographyCompletedNCT00500344Phase 1
- A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
- Unilateral Bevacizumab for Bilateral Diabetic Macular EdemaWithdrawnNCT00496405Phase 4
- A Phase I/II Study of Sunitinib and DacarbazineTerminatedNCT00496223Phase 1/2
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
- A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00483834Phase 2
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
- Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00482755Phase 2
- CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to TreatmentCompletedNCT00482521Phase 1
- Bevacizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00482495Phase 2
- A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for MyelosuppressionCompletedNCT00482261Phase 2
- A Study of Neoadjuvant Sutent for Patients With Renal Cell CarcinomaTerminatedNCT00480935Phase 2
- Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal CancerCompletedNCT00479817Phase 2
- A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer PatientsCompletedNCT00479076Phase 1
- Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00478959Phase 2
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
- Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyCompletedNCT00470977Phase 1/2
- EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT00470678Phase 3
- Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
- Safety and Efficacy Study of Thalomid in Patients With Chronic PancreatitisTerminatedNCT00469703Phase 2
- Treatment Study Using Bevacizumab for Patients With Adrenocortical CarcinomaWithdrawnNCT00469469Phase 2
- A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMDCompletedNCT00469352Phase 3
- Scotoma Reduction in AMD Patients Treated With RanibizumabCompletedNCT00467935Phase 1/2
- Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00467194Phase 1
- AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With SorafenibCompletedNCT00467025Phase 2
- Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast CancerCompletedNCT00467012Phase 2
- Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.CompletedNCT00466895Phase 1
- TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular DegenerationTerminatedNCT00464347Phase 2
- Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard TherapyCompletedNCT00463203Phase 2
- Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasCompletedNCT00463073Phase 2
- Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsCompletedNCT00462553Phase 1
- Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic CancerCompletedNCT00460174Phase 2
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary TumorWithdrawnNCT00458315Phase 2
- Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by ItselfWithdrawnNCT00457678Phase 2
- Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel FormationCompletedNCT00457145Phase 1
- Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel FormationCompletedNCT00457067Phase 1
- Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200CompletedNCT00455910Phase 2
- Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMDStatus unknownNCT00455871Not applicable
- Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple MyelomaCompletedNCT00452569Phase 3
- Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory NeuroblastomaCompletedNCT00450827Phase 1
- Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerStatus unknownNCT00450203Phase 2/3
- Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerTerminatedNCT00450008Phase 2
- Combination Therapy for Neovascular Age Related Macular DegenerationWithdrawnNCT00447031Not applicable
- A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's DiseaseCompletedNCT00446433Phase 2
- Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNCT00445900Phase 2
- Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00445406Phase 2
- Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell CarcinomaCompletedNCT00444314Phase 2
- Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal CancerCompletedNCT00444041Phase 1/2
- GEM05 for Patients With Multiple Myeloma More Than 65 Years OldCompletedNCT00443235Phase 3
- Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney CancerTerminatedNCT00440973Phase 2
- Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular EdemaCompletedNCT00440609Phase 1/2
- Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple MyelomaStatus unknownNCT00438841Phase 2
- Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT00438737Phase 2
- Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsCompletedNCT00437372Phase 1
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of MyelodysplasiaStatus unknownNCT00434239Early Phase 1
- 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)Status unknownNCT00433927Phase 3
- Maintenance Therapy Using Lenalidomide in MyelomaCompletedNCT00430365Phase 3
- Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaCompletedNCT00430261Phase 2
- Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVCompletedNCT00429962Phase 3
- Bevacizumab and Bortezomib in Patients With Advanced MalignancyCompletedNCT00428545Phase 1
- Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDCompletedNCT00426998Phase 2
- Proton Therapy and Bevacizumab for Primary Liver TumorsTerminatedNCT00426829Phase 1
- Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00425646Phase 2
- Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31]Status unknownNCT00424229Phase 2
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT00423059Not applicable
- A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
- A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
- A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic LeukemiaCompletedNCT00419250Phase 1
- Intravitreal Bevacizumab for the Treatment of Central Serous ChorioretinopathyWithdrawnNCT00418431Phase 2/3
- Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic SclerosisTerminatedNCT00418132Phase 1
- Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)TreatmentTerminatedNCT00417833Phase 2/3
- Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular EdemaWithdrawnNCT00417716Phase 3
- Bevacizumab in Treating Patients With Advanced Solid TumorsCompletedNCT00416637Phase 1
- Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415116Phase 1
- Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple MyelomaCompletedNCT00415064Phase 1
- Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)CompletedNCT00413829Phase 2
- Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic MelanomaCompletedNCT00412581Phase 1
- Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT00411593Phase 1/2
- Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By SurgeryTerminatedNCT00410774Phase 1/2
- Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal CancerWithdrawnNCT00408772Phase 2
- Efficacy of SU 011248 in Head And Neck CarcinomaTerminatedNCT00408252Phase 2
- Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)CompletedNCT00407719Phase 1
- Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaCompletedNCT00407459Phase 2
- Intravitreal Bevacizumab for Inflammatory Neovascular MembranesWithdrawnNCT00407121Phase 3
- Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma PatientsCompletedNCT00406978Phase 1/2
- Lucentis for Central Retinal Vein Occlusion (CRVO)CompletedNCT00406796Phase 1
- Efficacy of Retreatments With Intravitreal BevacizumabTerminatedNCT00406744Phase 3
- Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein OcclusionCompletedNCT00406471Phase 1
- Effect of Avastin in Juxtafoveal TelangiectasiasWithdrawnNCT00406380Phase 3
- Intravitreal Bevacizumab in Agioid StreaksCompletedNCT00406250Phase 1
- Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)WithdrawnNCT00406172Phase 3
- Study of ATN-224 in Patients With Prostate CancerStatus unknownNCT00405574Phase 2
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerStatus unknownNCT00404404Phase 2
- Intravitreal Ranibizumab Treatment of Central Serous ChorioretinopathyCompletedNCT00403325Phase 1
- Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular DegenerationWithdrawnNCT00403156Phase 1